FUNSAT
Commercial- Indications
- Cognitive assessment, Functional skills assessment
Company intelligence / Profile preview
i‑Function has demonstrated through NIH-funded studies that its digital tools can improve functional skills by 40–60% in older adults with MCI or normal cognition, achieving high confidence levels (>97%) with just two hours per week of training. The company is preparing to commercialize its LASSI-D screener for use by clinicians, researchers, pharmaceutical companies, and CROs to identify MCI more efficiently than current methods.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on i-Function.